Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1533 Articles

Chris Lange | Jun 25, 2015 at 8:10 AM EDT

Short Sellers Become More Focused on Big Pharma

The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Chris Lange | Jun 10, 2015 at 8:30 AM EDT

Short Sellers Back Off Big Pharma

The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Jun 8, 2015 at 1:00 PM EDT

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical…

Jon C. Ogg | Jun 7, 2015 at 9:40 AM EDT

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

This coming week is likely to be a serious one in the fight against cholesterol. FDA panels are evaluating more…

Lee Jackson | May 28, 2015 at 10:20 AM EDT

3 Top Value Stock Picks to Buy for This Week

Investors looking to move down in volatility but stay fully invested may want to consider moving capital to any of…

Chris Lange | May 28, 2015 at 9:30 AM EDT

Short Sellers More Selective on Big Pharma Stocks

The short interest data has been released for the May 15 settlement date and for the selected pharmaceutical stocks, short…

Lee Jackson | May 22, 2015 at 9:15 AM EDT

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug…

Paul Ausick | May 13, 2015 at 4:01 PM EDT

The 4 Stocks That Drove the DJIA Down on Wednesday

thinkstockMay 13, 2015: Markets opened higher on Wednesday but were able to eke out just modest gains by the end…

Chris Lange | May 12, 2015 at 9:50 AM EDT

Short Sellers Keep Strong Bets Against Big Pharma

The April 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Trey Thoelcke | May 12, 2015 at 6:28 AM EDT

The 5 Most Shorted NYSE Stocks in April

The five most shorted stocks trading on the New York Stock Exchange remained the same between the April 15 and…

Lee Jackson | May 8, 2015 at 9:20 AM EDT

4 Pharmaceutical Companies Leading the Breast Cancer Fight

In a new report, the RBC team focused on the companies that are making the most progress with treatments for…

Paul Ausick | May 6, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the DJIA on Wednesday

thinkstockMay 6, 2015: Markets opened higher on Wednesday but soon sank as growth expectations for the U.S. economy dimmed again.…

Chris Lange | May 5, 2015 at 10:50 AM EDT

Top Credit Suisse Major Pharma Stock Picks to Buy

Credit Suisse has released a report that detailed its top picks for pharmaceutical stocks for the rest of 2015.

Jon C. Ogg | Apr 29, 2015 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: AK Steel, NOV, Pfizer, Stratasys, Twitter, Wynn and More

Wednesday's top analyst upgrades, downgrades and initiations include AK Steel, National Oilwell Varco, Pfizer, Stratasys, Twitter and Wynn Resorts.

Jon C. Ogg | Apr 28, 2015 at 8:00 AM EDT

Pfizer Dodges a Bullet on Earnings

Pfizer has reported better-than-expected first-quarter earnings and revenue and offered guidance.

1 … 62 63 64 65 66 … 103

Pfizer : PFE

All Pfizer Articles

Short Sellers Become More Focused on Big Pharma

Short Sellers Back Off Big Pharma

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

3 Top Value Stock Picks to Buy for This Week

Short Sellers More Selective on Big Pharma Stocks

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

The 4 Stocks That Drove the DJIA Down on Wednesday

Short Sellers Keep Strong Bets Against Big Pharma

The 5 Most Shorted NYSE Stocks in April

4 Pharmaceutical Companies Leading the Breast Cancer Fight

The 4 Stocks That Weighed on the DJIA on Wednesday

Top Credit Suisse Major Pharma Stock Picks to Buy

Top Analyst Upgrades and Downgrades: AK Steel, NOV, Pfizer, Stratasys, Twitter, Wynn and More

Pfizer Dodges a Bullet on Earnings

The $4.2 Million Couple Left New York to Save on Roth Conversions. One Medicare Bill Followed Them to Florida.

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

The $4.2 Million Couple Left New York to Save on Roth Conversions. One Medicare Bill Followed Them to Florida.

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

The $4.2 Million Couple Left New York to Save on Roth Conversions. One Medicare Bill Followed Them to Florida.

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

Pfizer : PFE

All Pfizer Articles

Short Sellers Become More Focused on Big Pharma

Short Sellers Back Off Big Pharma

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

3 Top Value Stock Picks to Buy for This Week

Short Sellers More Selective on Big Pharma Stocks

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

The 4 Stocks That Drove the DJIA Down on Wednesday

Short Sellers Keep Strong Bets Against Big Pharma

The 5 Most Shorted NYSE Stocks in April

4 Pharmaceutical Companies Leading the Breast Cancer Fight

The 4 Stocks That Weighed on the DJIA on Wednesday

Top Credit Suisse Major Pharma Stock Picks to Buy

Top Analyst Upgrades and Downgrades: AK Steel, NOV, Pfizer, Stratasys, Twitter, Wynn and More

Pfizer Dodges a Bullet on Earnings

The $4.2 Million Couple Left New York to Save on Roth Conversions. One Medicare Bill Followed Them to Florida.

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

Featured Reads

The $4.2 Million Couple Left New York to Save on Roth Conversions. One Medicare Bill Followed Them to Florida.

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.